Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Implant Sciences Corp. (AMEX:IMX)

No earlier versions found for this Subject.

Return to Implant Sciences Corp. (AMEX:IMX)

Implant Sciences Corporation develops products for the medical device and explosives detection industry using ion implantation and thin film coatings of radioactive and non-radioactive materials. The Company has received Food and Drug Administration 510(k) clearance to market its I-Plant Iodine-125 radioactive seed for the treatment of prostate cancer. It also has under development interventional cardiology devices and temporary coronary brachytherapy systems for the prevention of restenosis (reclosure of the artery after balloon angioplasty). In addition, the Company modifies the surface characteristics of orthopedic joint implants to reduce polyethylene wear, thereby increasing the life of the implant, and provides ion implantation of electronic dopants for the semiconductor industry. The Company is developing an explosives detection device to be used in the detection of trace residues of explosives.